# BAG6 notes

## PN framing

- BAG6 is a proteostasis boundary-case gene rather than a canonical BAG-family Hsp70 nucleotide-exchange factor. Its C-terminal BAG-like region is a mock/noncanonical BAG domain and is better treated as a UBL4A-binding BAGS module than as a canonical Hsp70-binding BAG domain [PMID:25535373 Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domain, "Bag6-BAG is not a canonical BAG domain"] [PMID:25713138 Structure of a BAG6-Ubl4a complex reveals a novel binding interface that functions in tail-anchored protein biogenesis, "previously classified as a BAG domain, were completely distinct from those of the canonical BAG domain"].
- This matches the PN caution that BAG6 sits between ER proteostasis/GET-pathway targeting and UPS-associated chaperone roles, rather than fitting cleanly into a standard BAG-domain cochaperone bucket.

## Core proteostasis biology

- The strongest BAG6 function is cytosolic handling of hydrophobic client proteins. BAG6, UBL4A, and TRC35 form a ribosome-associated complex that captures tail-anchored membrane proteins and passes them to TRC40 for ER delivery [PMID:20676083 A ribosome-associating factor chaperones tail-anchored membrane proteins, "facilitates TA protein capture by TRC40"] [PMID:25535373 Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domain, "facilitates tail-anchored substrate transfer from small glutamine-rich tetratricopeptide repeat-containing protein α to TRC40"].
- BAG6 is also an ATP-independent holdase for hydrophobic quality-control clients. In ERAD, it keeps retrotranslocated substrates soluble and improves their proteasomal disposal [PMID:21636303 A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation, "maintains polypeptides in soluble states for proteasome degradation"] [PMID:23665563 A ubiquitin-like domain recruits an oligomeric chaperone to a retrotranslocation complex in endoplasmic reticulum-associated degradation, "anchor a disordered chaperone oligomer to the site of retrotranslocation to prevent protein aggregation in ERAD"].
- BAG6 couples targeting and degradation for mislocalized membrane proteins. Clients that fail productive targeting can be ubiquitinated through BAG6-linked machinery rather than simply handed back to folding systems [PMID:21743475 Protein targeting and degradation are coupled for elimination of mislocalized proteins, "A subset of these Bag6 complex clients are transferred to TRC40 for insertion into the membrane, whereas the remainder are rapidly ubiquitinated"] [PMID:24981174 Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6, "RNF126 is the primary Bag6-dependent ligase"] [PMID:23129660 SGTA antagonizes BAG6-mediated protein triage, "SGTA antagonizes BAG6-mediated protein triage"].
- ER-stress-induced pre-emptive quality control is supported but should stay narrower than generic ERAD. Bag6 contributes to degradation of rerouted ER pQC substrates during stress [PMID:26565908 Pre-emptive Quality Control Protects the ER from Protein Overload via the Proximity of ERAD Components and SRP, "Bag6 and p97 contribute to the degradation of ER pQC substrates"].

## Contextual, non-core roles

- BAG6 has a documented nuclear stress-response role, promoting p300-mediated p53 acetylation and DNA-damage-associated apoptosis [PMID:17403783 HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53, "Bat3 is required for the acetylation of p53 in response to DNA damage"]. This is real but not the core proteostasis identity.
- Exosomal BAG6 can function as an NKp30 ligand and modulate NK-cell activation in tumor or dendritic-cell contexts [PMID:18055229 Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells, "BAT3 ... engages the NKp30 receptor on natural killer cells"] [PMID:18852879 Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function, "BAT3-positive exosomes ... activation of NK cell-mediated cytokine release"]. This should be kept distinct from the core GET/UPS quality-control role.
- BAG6 is genuinely nucleo-cytoplasmic, and TRC35/GET4 binding helps retain it in the cytosol where the main proteostasis functions occur [PMID:29042515 Structural basis for regulation of the nucleo-cytoplasmic distribution of Bag6 by TRC35, "TRC35 binding is critical ... to retain Bag6 in the cytosol"].

## 2026-05-29 - PROTEOSTASIS PN ER-protein-transport pass

- PN places BAG6 under `ER proteostasis > Protein transport > GET pathway component`. The narrow GET-pathway mapping to `GO:0006620 post-translational protein targeting to endoplasmic reticulum membrane` is appropriate and is already represented in the local review/GOA.
- The parent `ER proteostasis > Protein transport` mapping would additionally propagate broad `GO:0015031 protein transport` to BAG6. This is directionally related but less informative than the reviewed BAG6 terms, especially `GO:0071816 tail-anchored membrane protein insertion into ER membrane` and `GO:0006620 post-translational protein targeting to endoplasmic reticulum membrane` [PMID:20676083 "facilitates TA protein capture by TRC40"; PMID:25535373 "facilitates tail-anchored substrate transfer"].
- Working curation conclusion: keep the GET-pathway-specific propagation for BAG6, but do not add the broad parent `GO:0015031 protein transport` candidate.